Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2011-2021


April 11, 2011
119 Pages - SKU: VSG6355087
License type:
Table of Contents Related Reports
Cameroon Pharmaceuticals and Healthcare Report Q3 2013
5/8/2013 | published by: Business Monitor International
BMI View: Despite the strong growth potential of its pharmaceutical market, we believe Cameroon isunlikely to be of significant interest to multinational pharmaceutical firms. The country's shortcomingsinclude poor public health provision and rampant corruption. Consequently  |  read more...
$1,175.00
Namibia Pharmaceuticals and Healthcare Report Q3 2013
5/8/2013 | published by: Business Monitor International
BMI View: We expect Namibia's negative pharmaceutical trade balance to widen as demand for medicinescontinues to be met by imports, and poor local manufacturing sees exports contract in the medium term.Headline Expenditure Forecasts Pharmaceuticals: NAD2.20bn  |  read more...
$1,175.00
Nigeria Pharmaceuticals and Healthcare Report Q3 2013
5/8/2013 | published by: Business Monitor International
Executive Summary BMI View: Boosting bilateral co-operation between Nigerian buyers and Indian drugmakers will directlyobstruct the Nigerian government's goal to increase self-sufficiency in medicines production. We do notbelieve implementing a selected import ban on pharmaceuticals should  |  read more...
$1,175.00
Croatia Pharmaceuticals and Healthcare Report Q3 2013
5/15/2013 | published by: Business Monitor International
Executive Summary BMI View: Croatia's entrance into the EU will accelerate its economic liberalisation and the developmentof the country's private sector. It is also likely to bring about an influx of EU funding in modernising thecountry's  |  read more...
$1,295.00
Sudan and South Sudan Pharmaceuticals and Healthcare Report Q3 2013
5/15/2013 | published by: Business Monitor International
BMI View: Sudan will remain one of the least attractive countries in the Middle East/Africa region due tolow pharmaceutical and healthcare expenditure. The government's low commitment to healthcare,combined with political and economic uncertainties, will remain  |  read more...
$1,295.00
Central America Pharmaceuticals and Healthcare Report Q3 2013
5/1/2013 | published by: Business Monitor International
BMI View: Commercial incentives for foreign drugmakers to expand in the Central Americanpharmaceutical market are limited by the region's relatively low per capita pharmaceutical spending andmarket growth. However, the heavy reliance on imported medicine in  |  read more...
$1,175.00
Qatar Pharmaceuticals and Healthcare Report Q2 2013
5/1/2013 | published by: Business Monitor International
BMI View: Qatar represents a largely risk-free proposition for multinational drug manufacturers,although the potential returns are modest, on the account of a small overall market size. Additionally,despite the authorities' desire to increase the domestic medicine  |  read more...
$1,175.00
China Pharmaceutical Guidebook Series (4) 2013 Edition Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application for Imported Traditional Chinese Medicines and Natural Medi
5/20/2013 | published by: Access China Management Consulting Ltd.
The traditional medicines in Orient, especially, the traditional Chinese medicines are always regarded by occidental as mysterious medicines. Until today not only the chemical composition of traditional Chinese medicines almost can not been expressed by  |  read more...
$750.00
PharmaSphere: Early-Stage Technology Transfer Collaborations - Enabling Platform Technologies & Deal Synergies between Academia and the Pharmaceutical Industry
4/30/2013 | published by: GlobalData
PharmaSphere: Early-Stage Technology Transfer Collaborations - Enabling Platform Technologies & Deal Synergies between Academia and the Pharmaceutical Industry Summary PharmaSphere: Early-Stage Technology Transfer Collaborations - Enabling Platform Technologies & Deal Synergies between Academia and the Pharmaceutical Industry  |  read more...
$2,995.00
Pneumonia Treatment Drugs Markets in China
5/1/2013 | published by: Asia Market Information & Development Company
China's demand for pneumonia treatment drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic  |  read more...
$2,000.00
 
Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Related Markets

Regulation & Policy Reports
 
 

Share this report


Other tasks

 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!